Safety and efficacy of single agent rovalpituzumab tesirine in small cell lung cancer (SCLC)
1 विचारों
• 07/14/23
0
0
एम्बेड
administrator
ग्राहकों
Press brief by Charles Rudin, MD, PhD of the Memorial Sloan Kettering Cancer Center, New York, NY, at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.
और दिखाओ
फेसबुक टिप्पणियाँ
SORT BY-
सबसे ऊपर की टिप्पणी
-
नवीनतम टिप्पणियां